GPRE Green Plains Inc.
Industrial Organic Chemicals · Nasdaq · SEC CIK 1309402 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-19.1%
TTM net income YoY204.9%
TTM EPS YoY186.3%
Revenue 3-yr CAGR-19.6%
Net income 3-yr CAGR—
Margins
Gross margin21.1%
Operating margin10.7%
Net margin10.9%
FCF margin4.4%
EBITDA margin15.9%
Returns
ROE22.9%
ROA12.1%
ROIC (approx.)18.4%
Asset turnover1.11x
Leverage & solvency
Liabilities / assets44.7%
Debt / equity0.48x
Current ratio2.31x
Interest coverage5.76x
Cash quality & payout
Operating cash flow / net income0.58x
Accruals ratio5.1%
Payout ratio—
Capex / revenue1.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $495.99M | $446.22M | $445.80M | $428.85M | $508.49M | $552.83M | $601.51M | $584.02M |
| Cost of revenue | $353.18M | $333.19M | $357.86M | $388.70M | $429.80M | $511.26M | $598.48M | $577.87M |
| Gross profit | $142.81M | $113.03M | $87.95M | $40.15M | $78.69M | $41.57M | $3.04M | $6.15M |
| SG&A expense | $26.64M | $21.71M | $19.54M | $22.86M | $29.34M | $27.61M | $42.91M | $25.62M |
| Operating income | $92.59M | $67.87M | $44.77M | -$10.49M | $60.39M | -$28.36M | -$62.26M | -$40.91M |
| Interest expense | $8.09M | $8.13M | $11.48M | $6.09M | $47.76M | $13.90M | $8.91M | $7.73M |
| Pretax income | $86.25M | $61.71M | $36.36M | -$14.99M | $11.04M | -$41.67M | -$71.69M | -$46.39M |
| Income tax | $700,000 | -$5.49M | $2.92M | -$28.51M | $883,000 | $2.29M | $106,000 | $6.98M |
| Net income | $85.44M | $67.15M | $32.94M | $11.94M | $11.93M | -$72.24M | -$72.91M | -$54.94M |
| EBITDA | $116.17M | $91.32M | $68.41M | $13.03M | $85.36M | -$803,000 | -$39.87M | -$19.46M |
| EPS (basic) | 1.23 | 0.97 | 0.48 | — | 0.17 | -1.09 | -1.14 | — |
| EPS (diluted) | 1.03 | 0.83 | 0.42 | — | 0.17 | -1.09 | -1.14 | — |
| Weighted avg. shares (diluted) | 85.50M | 84.49M | 84.14M | — | 77.87M | 66.49M | 64.07M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $159.99M | $185.38M | $95.72M | $182.32M | $211.62M | $152.72M | $126.60M | $209.40M |
| Receivables | $90.67M | $79.58M | $85.86M | $74.37M | $84.94M | $78.47M | $97.09M | $94.90M |
| Current assets | $707.32M | $625.45M | $542.27M | $522.54M | $446.59M | $436.21M | $450.31M | $569.03M |
| PP&E, net | $909.10M | $918.05M | $928.68M | $957.26M | $958.26M | $1.07B | $1.05B | $1.04B |
| Intangibles | — | — | — | $10.48M | — | — | — | $12.67M |
| Total assets | $1.73B | $1.66B | $1.59B | $1.58B | $1.53B | $1.61B | $1.67B | $1.78B |
| Current liabilities | $306.38M | $313.75M | $318.03M | $268.71M | $266.09M | $297.00M | $325.74M | $385.69M |
| Short-term debt | $69.73M | $69.51M | $69.32M | $3.92M | $2.04M | $2.12M | $2.12M | $2.12M |
| Long-term debt | $385.31M | $387.18M | $388.92M | $361.99M | $306.37M | $426.00M | $432.24M | $432.46M |
| Total debt | $455.04M | $456.69M | $458.24M | $365.92M | $308.41M | $428.13M | $434.35M | $434.58M |
| Total liabilities | $772.91M | $787.22M | $795.73M | $812.92M | $757.53M | $872.08M | $859.38M | $907.64M |
| Shareholders' equity | $955.17M | $869.93M | $785.18M | $766.25M | $768.92M | $735.18M | $797.51M | $865.22M |
| Net debt | $295.06M | $271.30M | $362.52M | $183.60M | $96.79M | $275.41M | $307.75M | $225.18M |
| Shares outstanding | 70.60M | 70.10M | 70.04M | 69.83M | 71.93M | 65.59M | 65.39M | 64.71M |
| Cash flow statement | ||||||||
| Operating cash flow | $583,000 | $86.27M | -$39.50M | $67.34M | $39.77M | $58.80M | -$55.04M | -$26.97M |
| Capital expenditure | $11.90M | $10.69M | $6.45M | $5.33M | $4.01M | $11.14M | $16.71M | $27.26M |
| Free cash flow | -$11.32M | $75.58M | -$45.95M | $62.01M | $35.76M | $47.65M | -$71.75M | -$54.23M |
| Investing cash flow | -$11.90M | -$10.69M | -$4.45M | -$8.84M | $203.32M | -$11.63M | -$20.71M | -$27.43M |
| Financing cash flow | -$6.69M | -$15.64M | -$3.04M | -$39.99M | -$184.18M | -$21.05M | -$7.04M | $11.84M |
| Depreciation & amortization | $23.57M | $23.45M | $23.64M | $23.52M | $24.97M | $27.56M | $22.39M | $21.45M |
| Stock-based compensation | $2.00M | $2.30M | $1.89M | $3.39M | $2.60M | $2.30M | $8.84M | -$1.89M |
| Dividends paid | $0 | — | — | $721,000 | $0 | — | — | $5.17M |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.